Prevalence of abnormal cardiovascular magnetic resonance findings in athletes recovered from COVID-19 infection: A systematic review and meta-analysis

Tsampasian, Vasiliki, Androulakis, Emmanuel, Catumbela, Ricardo, Gati, Sabiha, Papadakis, Michael and Vassiliou, Vassilios S. ORCID: https://orcid.org/0000-0002-4005-7752 (2024) Prevalence of abnormal cardiovascular magnetic resonance findings in athletes recovered from COVID-19 infection: A systematic review and meta-analysis. Journal of Clinical Medicine, 13 (11). ISSN 2077-0383

[thumbnail of jcm-13-03290]
Preview
PDF (jcm-13-03290) - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Background: Competitive sports and high-level athletic training result in a constellation of changes in the myocardium that comprise the ‘athlete’s heart’. With the spread of the COVID-19 pandemic, there have been concerns whether elite athletes would be at higher risk of myocardial involvement after infection with the virus. This systematic review and meta-analysis evaluated the prevalence of abnormal cardiovascular magnetic resonance (CMR) findings in elite athletes recovered from COVID-19 infection. Methods: The PubMed, Cochrane and Web of Science databases were systematically search from inception to 15 November 2023. The primary endpoint was the prevalence of abnormal cardiovascular magnetic resonance findings, including the pathological presence of late gadolinium enhancement (LGE), abnormal T1 and T2 values and pericardial enhancement, in athletes who had recovered from COVID-19 infection. Results: Out of 3890 records, 18 studies with a total of 4446 athletes were included in the meta-analysis. The pooled prevalence of pathological LGE in athletes recovered from COVID-19 was 2.0% (95% CI 0.9% to 4.4%, I2 90%). The prevalence of elevated T1 and T2 values was 1.2% (95% CI 0.4% to 3.6%, I2 87%) and 1.2% (95% CI 0.4% to 3.7%, I2 89%), respectively, and the pooled prevalence of pericardial involvement post COVID-19 infection was 1.1% (95% CI 0.5% to 2.5%, I2 85%). The prevalence of all abnormal CMR findings was much higher among those who had a clinical indication of CMR. Conclusions: Among athletes who have recently recovered from COVID-19 infection, there is a low prevalence of abnormal CMR findings. However, the prevalence is much higher among athletes with symptoms and/or abnormal initial cardiac screening. Further studies and longer follow up are needed to evaluate the clinical relevance of these findings and to ascertain if they are associated with adverse events.

Item Type: Article
Additional Information: Data Availability Statement: No new data were created in this study as data from already published studies were analysed. Data sharing is not applicable to this article. Funding information: This research received no external funding. V.T. is supported by an NIHR Doctoral Research Fellowship (NIHR303306). The views expressed in this publication are those of the authors and not those of the funders.
Uncontrolled Keywords: cardiovascular magnetic resonance,covid-19,sports cardiology,medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 19 Jul 2024 11:32
Last Modified: 16 Oct 2024 00:04
URI: https://ueaeprints.uea.ac.uk/id/eprint/95967
DOI: 10.3390/jcm13113290

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item